Hyperammonemia due to valproic acid in the psychiatric setting.
Carr
Russell B
RB
Northern Virginia Mental Health Institute, Falls Church, Virginia, USA. rbcarr@bethesda.med.navy.mil
Shrewsbury
Kerrie
K
D000328:Adult; D000368:Aged; D001714:Bipolar Disorder / Q000188:drug therapy / Q000523:psychology; D002331:Carnitine / Q000172:deficiency / Q000378:metabolism / Q000627:therapeutic use; D002648:Child; D005260:Female; D006801:Humans; D022124:Hyperammonemia / Q000139:chemically induced* / Q000523:psychology / Q000628:therapy; D008099:Liver / Q000378:metabolism; D008875:Middle Aged; D011618:Psychotic Disorders / Q000188:drug therapy* / Q000523:psychology; D012107:Research Design / Q000639:trends; D014635:Valproic Acid / Q000009:adverse effects* / Q000627:therapeutic use
D014635:Valproic Acid; D002331:Carnitine